MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Cuts Holdings in DaVita Inc. $DVA

Key Points

• MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH significantly reduced its holdings in DaVita Inc. by 48.2% in the second quarter, now owning 25,579 shares valued at approximately $3.64 million.
• This reduction in holdings follows activity from other institutional investors, with notable increases from firms like UMB Bank n.a. and the National Pension Service, which raised their stakes in DaVita by 65.5% and 74.3% respectively during the first quarter.
• Despite recent adjustments in holdings, DaVita Inc. reported better-than-expected quarterly earnings, with an EPS of $2.95, surpassing analyst estimates by $0.25, and projecting FY 2025 EPS guidance of 10.200-11.300.

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH trimmed its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 48.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 25,579 shares of the company's stock after selling 23,794 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH's holdings in DaVita were worth $3,644,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC boosted its stake in DaVita by 2.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after purchasing an additional 69 shares during the last quarter. UMB Bank n.a. boosted its stake in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of DaVita by 8.9% in the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after buying an additional 79 shares during the last quarter. Mather Group LLC. boosted its stake in shares of DaVita by 7.0% in the 1st quarter. Mather Group LLC. now owns 1,201 shares of the company's stock worth $184,000 after buying an additional 79 shares during the last quarter. Finally, National Pension Service boosted its stake in shares of DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company's stock worth $30,000 after buying an additional 84 shares during the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other DaVita news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by corporate insiders.

DaVita Price Performance

NYSE:DVA opened at $133.65 on Thursday. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The business's 50-day simple moving average is $136.62 and its two-hundred day simple moving average is $140.81. The stock has a market cap of $9.56 billion, a PE ratio of 13.14, a P/E/G ratio of 0.95 and a beta of 1.13. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The business's quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the firm earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Bank of America dropped their price target on DaVita from $145.00 to $140.00 and set an "underperform" rating on the stock in a research note on Wednesday, September 10th. Barclays dropped their price target on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Saturday, September 13th. Finally, Truist Financial set a $148.00 target price on DaVita in a report on Friday, August 8th. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Reduce" and an average price target of $158.00.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.